TAK
Takeda Pharmaceutical·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
TAK Filings
Filing Date
Form Description
Form Type
2025-12-04
Form 144 - Report of proposed sale of securities
Ownership
2025-12-04 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-28
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-28 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-13
Form 13F-HR - Quarterly report filed by institutional managers, Holdings
Ownership
2025-11-13 · Ownership
Form 13F-HR - Quarterly report filed by institutional managers, Holdings
2025-10-30
Takeda Pharmaceutical Company Limited (TAK) Q2 2026 Earnings Call Transcript
Earnings Call
2025-10-30 · Earnings Call
Takeda Pharmaceutical Company Limited (TAK) Q2 2026 Earnings Call Transcript
2025-10-30
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-10-30 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-30
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-30 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-30
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-30 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-01
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-01 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-09-25
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-09-25 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-09-19
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-09-19 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
